Stock Research for AEMD


Featured Broker: Ally Invest

Get the due diligence for another stock.


AEMD Stock Chart & Research Data

The AEMD chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the AEMD chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


AEMD Due diligence Resources & Stock Charts

The AEMD stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View AEMD Detailed Price Forecast - CNN Money CNN View AEMD Detailed Summary - Google Finance
Yahoo View AEMD Detailed Summary - Yahoo! Finance Zacks View AEMD Stock Research & Analysis -

Stock Analysis

TradeIdeas View AEMD Trends & Analysis - Trade-Ideas Barrons View AEMD Major Holders - Barrons
NASDAQ View AEMD Call Transcripts - NASDAQ Seeking View AEMD Breaking News & Analysis - Seeking Alpha
Spotlight View AEMD Annual Report - OTC Report View AEMD OTC Short Report -
TradeKing View AEMD Fundamentals - TradeKing Charts View AEMD SEC Filings - Bar Chart
WSJ View Historical Prices for AEMD - The WSJ Morningstar View Performance/Total Return for AEMD - Morningstar
MarketWatch View the Analyst Estimates for AEMD - MarketWatch CNBC View the Earnings History for AEMD - CNBC
StockMarketWatch View the AEMD Earnings - StockMarketWatch MacroAxis View AEMD Buy or Sell Recommendations - MacroAxis
Bullish View the AEMD Bullish Patterns - American Bulls Short Pains View AEMD Short Pain Metrics -

Social Media Mentions

StockTwits View AEMD Stock Mentions - StockTwits PennyStocks View AEMD Stock Mentions - PennyStockTweets
Twitter View AEMD Stock Mentions - Twitter Invest Hub View AEMD Investment Forum News - Investor Hub
Yahoo View AEMD Stock Mentions - Yahoo! Message Board Seeking Alpha View AEMD Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for AEMD - Insider Cow View Insider Transactions for AEMD - Insider Cow
CNBC View AEMD Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for AEMD - OTC Markets
Yahoo View Insider Transactions for AEMD - Yahoo! Finance NASDAQ View Institutional Holdings for AEMD - NASDAQ

Stock Charts

FinViz View AEMD Stock Insight & Charts - StockCharts View AEMD Investment Charts -
BarChart View AEMD Stock Overview & Charts - BarChart Trading View View AEMD User Generated Charts - Trading View

Latest Financial News for AEMD

Loss-Making Aethlon Medical Inc (NASDAQ:AEMD) Expected To Breakeven
Posted on Wednesday June 27, 2018

Aethlon Medical Inc’s (NASDAQ:AEMD): Aethlon Medical, Inc., a medical device company, focuses on creating devices that address unmet medical needs in health and biodefense worldwide. On 31 March 2018, theRead More...

Guy Cipriani Joins Aethlon Medical's Board of Directors
Posted on Monday June 25, 2018

SAN DIEGO, June 25, 2018 /PRNewswire/ -- Aethlon Medical, Inc. (AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense, today announced the appointment of Guy Cipriani to its Board of Directors. Mr. Cipriani qualifies as an independent director under the Nasdaq Rules. Mr. Cipriani is a business executive with nearly 20 years of experience in the pharmaceutical and biotech industries.

New Research: Key Drivers of Growth for Nicolet Bankshares, Vitamin Shoppe, Aethlon Medical, Barrett Business Services, Veracyte, and TPG Specialty Lending — Factors of Influence, Major Initiatives and Sustained Production
Posted on Thursday June 21, 2018

NEW YORK, June 21, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Nicolet ...

AEMD: AEMD In Active Discussions With FDA Regarding Hemopurifier Pathway
Posted on Wednesday June 13, 2018

Revenue of $75k, which was largely inline with our $89k estimate, relates entirely to a second milestone from the NCI cancer grant. Subsequent to the close of fiscal 2018, AEMD billed an additional $112k for work completed under this grant.

Stock Market & Investing Books

Enter a stock symbol to view the stock details.